Hepatitis B Virus Variants in an HIV-HBV Co-Infected Patient at Different Periods of Antiretroviral Treatment With and Without Lamivudine

BMC Infectious Diseases - United Kingdom
doi 10.1186/1471-2334-4-29
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Hepatitis B Virus (HBV) Variants in Hemodialysis Patients

2011English

Intensification With Pegylated Interferon During Treatment With Tenofovir in HIV-hepatitis B Virus Co-Infected Patients

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2016English

Characterization of Hepatitis B Virus and Human Immunodeficiency Virus Among HIV/HBV Co-Infected Patients From the Republic of Guinea

Problemy Osobo Opasnykh Infektsii
EpidemiologyInfectious DiseasesImmunologyMicrobiology
2019English

Characteristics and Outcomes of Antiretroviral-Treated HIV-HBV Co-Infected Patients in Canada?

BMC Infectious Diseases
Infectious Diseases
2019English

Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected With Hepatitis B Virus

Gut and Liver
HepatologyGastroenterology
2007English

Active Replication of Hepatitis B Virus (HBV) in HIV Type 1 and in HIV Type 2 Infected Patients

Revista do Instituto de Medicina Tropical de Sao Paulo
MedicineInfectious Diseases
1996English

Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients With or Without HIV Infection

HIV Clinical Trials
2013English

Hepatitis B Surface Antigen Concentrations in Patients With HIV/HBV Co-Infection

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy